Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MiOx: High-flow oxygen therapy for migraine in the emergency department
2022-501133-23-00Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of oxygen in migraine (2 arms), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Pain response at 30 minutes. Started May 2023; status: completed.
02
Drugs
oxygen
03
Conditions
migraine
Beyond the preview
Go deeper on 2022-501133-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501133-23-00.